DCOY earnings date and last-quarter result: last quarter miss, P/E -0.16. Updated 2026-07-23.
Decoy Therapeutics (DCOY) Research Hub
Decoy Therapeutics (DCOY) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.92035 USD (-5.12%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.16, market cap 0.00B. This hub links to the full technical, earnings and options research available for DCOY.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.92035 USD (-5.12%) |
| 52-week range | 0.9 USD – 8.33 USD |
| Trend regime | Range |
| 14-day RSI | 13.8 (Oversold) |
| Trailing P/E | -0.16 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for DCOY
Covered Call on DCOY: how it works, illustrative setup around the real 0.9204 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on DCOY: how it works, illustrative setup around the real 0.9204 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on DCOY: how it works, illustrative setup around the real 0.9204 USD price, max profit/loss, breakeven and when to use it. Educational.
DCOY technical analysis: range, last 0.92035 USD, RSI 13.8, 52w range 0.9 USD–8.33 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is DCOY in?
Decoy Therapeutics (DCOY) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is DCOY in an uptrend or downtrend?
As of 2026-10-26, DCOY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is DCOY's trailing P/E ratio?
DCOY's trailing P/E is -0.16, with a market cap of 0.00B. See the earnings research page for full valuation detail.